Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdMSC for Erectile and Cardiac Function in Aging Men
NCT02107118Phase 1Withdrawn
- Sponsor
- Baylor College of Medicine
- Start
- May 2015
- Primary completion
- Mar 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in erectile dysfunction (ED) and cardiovascular disease (CVD) comparing AdMSC with Placebo (2 arms). Primary endpoint: International Index of Erectile Function at 12 months. Planned start May 2015; status: withdrawn.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
erectile dysfunction (ED)cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02107118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107118.